Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
20 juin 2024 10h46 HE
|
Rapafusyn Pharmaceuticals
Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging or previously undruggable disease targets Financing...
Human Microbiome market is projected to grow at a CAGR of 25.0% by 2033: Visiongain
16 juin 2023 07h24 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the Human Microbiome Market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25.0 % during the forecast period 2023-2033. Visiongain has...
Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain
14 juin 2023 06h00 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the Nasal Drug Delivery Technology Market was valued at US$71.0 billion in 2022 and is projected to grow at a CAGR of 7.5% during the forecast period 2023-2033. ...
Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033: Visiongain
01 juin 2023 08h05 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the Allergy Immunotherapy Market was valued US$1,907.5 million in 2022 and is projected to grow at a CAGR of 7.6% during the forecast period 2023-2033. Visiongain...
Menopause Market is projected to grow at a CAGR of 5.4% by 2033: Visiongain
23 mai 2023 06h53 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the Menopause Market was valued at US$17.33 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033. Visiongain has...
Dental consumables market is estimated market is estimated to reach a market value of US$47,051.7 million by 2033: Visiongain
22 mai 2023 12h15 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the Global Dental Consumables Market is valued at US$21,759.4 million in 2023 and is expected to register a CAGR of 8.0% from 2023 to 2033. Visiongain has published...
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain
17 mai 2023 11h24 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the Rare Diseases Market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the forecast period 2023-2033. Visiongain has...
Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain Reports Ltd
04 mai 2023 12h22 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...
Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and Development
04 mai 2023 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 04, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), today announced that it has entered into a...
Nasal Drug Delivery Technology Market is Projected to Grow at a CAGR of 7.5% by 2033: Visiongain Reports Ltd
19 avr. 2023 11h58 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...